Table 1. Background characteristics and clinical parameters of the sample (n = 95).
| Characteristics | Mean (SD) | Median (min, max) | N (%) |
|---|---|---|---|
| Sex (male) | 72 (76%) | ||
| Gestational age (<37 wks) | 12 (13%) | ||
| Birth weight SDS | -1.0 (1.5) | -0.9 (-6.4, 1.2) | |
| Age at start | 6.3 (2.1) | 6.2 (1.3, 10.0) | |
| HSDS at start | -2.8 (0.7) | -2.6 (-5.6, -2.0) | |
| HSDS 1y after start GH | -2.1 (0.7) | -2.0 (-4.4, -1.0) | |
| HSDS 2y after start GH | -1.7 (0.7) | -1.6 (-4.2, -0.3) | |
| Adj-HSDS at start | -2.1 (0.9) | -2.1 (-4.7, -0.1) | |
| Adj-HSDS 1y after start GH | -1.4 (0.8) | -1.4 (-4.0, 0.2) | |
| Adj-HSDS 2y after start GH | -1.1 (0.8) | -1.1 (-3.6, 0.5) | |
| Weight SDS at start | -1.8 (1.1) | -1.9 (-5.2, 1.8) | |
| GH dose (mg/kg/wk) | 0.21 (0.10) | 0.21 (0.04, 0.83) | |
| GH max* | 4.9 (3.0) | 4.3 (0.47, 12.5) | |
| IoR first year | -0.4 (1.1) | -0.5 (-3.4, 4.1) | |
| IoR second year | -0.1 (1.1) | -0.1 (-3.5, 3.1) | |
| Adherence 0-1y | 80.8 (31.1) | 95.1 (0, 100) | |
| Adherence 1-2y | 81.5 (23.0) | 92.9 (0, 100) | |
| Adherence 0-2y | 81.1 (22.2) | 90.6 (7.4, 99.9) |
*Data available for n = 58